Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods

There is substantial evidence to link what we eat to the reduction of the risk of major chronic diseases and/or the improvement of functions. Thus, it is important for public health agencies and the food industry to facilitate the consumption of foods with particular health benefits by providing consumer products and messages based on scientific evidence. Although fragmentary advice is available from a range of sources, there is a lack of comprehensive scientific guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods. Such guidelines are needed both to support nutrition science in general, and to facilitate the substantiation of health claims. In the present study, which presents the consensus view of an International Life Sciences Institute Europe Expert Group that included senior scientists from academia and industry, the term ‘foods’ refers to foods, dietary supplements and food constituents, but not to whole diets. The present study is based on an initial survey of published papers, which identified the range and strengths and weaknesses of current methodologies, and was finalised following exchanges between representatives from industry, academia and regulatory bodies. The major factors involved in the design, conduct and reporting of studies are identified, summarised in a checklist table that is based on the Consolidated Standards of Reporting Trials guidelines, and elaborated and discussed in the text.

[1]  I. Borecki,et al.  Postprandial triacylglycerol metabolism is modified by the presence of genetic variation at the perilipin (PLIN) locus in 2 white populations. , 2008, The American journal of clinical nutrition.

[2]  王林,et al.  CONSORT , 2011 .

[3]  F. Branca,et al.  Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. , 2008, The American journal of clinical nutrition.

[4]  Feng Chen,et al.  Novel omics technologies in nutrition research. , 2008, Biotechnology advances.

[5]  P. Morgan International committee of medical journal editors. , 1983, Canadian Medical Association journal.

[6]  M. Cabana,et al.  Guide to designing, conducting, publishing, and communicating results of clinical studies involving probiotic applications in human participants , 2010, Gut microbes.

[7]  M. Palmer Clinical Trials: A Practical Approach , 1985 .

[8]  Catherine M Champagne,et al.  The evidence for dietary prevention and treatment of cardiovascular disease. , 2008, Journal of the American Dietetic Association.

[9]  Efsa Panel on Dietetic Products Scientific and technical guidance for the preparation and presentation of an application for authorisation of a health claim (revision 1) , 2011 .

[10]  B. Sandström Quality criteria in human experimental nutrition research. , 1995, European journal of clinical nutrition.

[11]  Draft Guidance Contains Nonbinding Recommendations Guidance for Industry ! Evidence-Based Review System for the Scientific Evaluation of Health Claims , 2007 .

[12]  R. Nahin,et al.  Guidance from an NIH Workshop on Designing, Implementing, and Reporting Clinical Studies of Soy Interventions1–4 , 2010, The Journal of nutrition.

[13]  廣畑 富雄,et al.  Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective , 2007 .

[14]  Peter Fayers,et al.  Randomized Clinical Trials: Design, Practice and Reporting , 2010 .

[15]  Ursel Wahrburg,et al.  What are the health effects of fat? , 2004, European journal of nutrition.

[16]  K. Krleza-Jeric Clinical Trial Registration: The Differing Views of Industry, the WHO, and the Ottawa Group , 2005, PLoS medicine.

[17]  N. Asp,et al.  Process for the Assessment of Scientific Support for Claims on Foods (PASSCLAIM): overall introduction , 2003, European journal of nutrition.

[18]  D. Moher,et al.  Issues related to the conduct of systematic reviews: a focus on the nutrition field. , 2008, The American journal of clinical nutrition.

[19]  D. DeMets,et al.  Fundamentals of Clinical Trials , 1982 .

[20]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2011, BMJ : British Medical Journal.

[21]  C. Cooper,et al.  PASSCLAIM – Bone health and osteoporosis , 2003, European journal of nutrition.

[22]  World Medical Association (WMA),et al.  Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects , 2009, Journal of the Indian Medical Association.

[23]  J. Lupton,et al.  Funding food science and nutrition research: financial conflicts and scientific integrity. , 2009, The Journal of nutrition.

[24]  J. Abraham The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use , 2009 .

[25]  F. Bellisle,et al.  PASSCLAIM, Process for the Assessment of Scientific Support for Claims on Foods , 2005 .

[26]  Uk-Prospective-Diabetes-Study-Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[27]  P. Jones,et al.  Optimizing clinical trial design for assessing the efficacy of functional foods. , 2010, Nutrition reviews.

[28]  S Senn,et al.  Analysis of serial measurements in medical research. , 1990, BMJ.

[29]  M. Hills,et al.  The two-period cross-over clinical trial. , 1979, British journal of clinical pharmacology.

[30]  J. Davis Clinical Trials: a Methodological Perspective, 2nd edn by S. Piantadosi , 2007 .

[31]  A. Zauber,et al.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .

[32]  M Thorogood,et al.  Dietary advice for reducing cardiovascular risk. , 2013, The Cochrane database of systematic reviews.

[33]  M. Hills,et al.  The two-period cross-over clinical trial. 1979. , 2004, British journal of clinical pharmacology.

[34]  J. Rafter,et al.  PASSCLAIM¶Process for the Assessment of Scientific Support for Claims on Foods , 2003 .

[35]  S A Bingham,et al.  Limitations of the various methods for collecting dietary intake data. , 1991, Annals of nutrition & metabolism.

[36]  J. German,et al.  PASSCLAIM – Diet-related cardiovascular disease , 2003, European journal of nutrition.

[37]  F. Bellisle,et al.  PASSCLAIM: consensus on criteria. , 2005, European journal of nutrition.

[38]  H. Hauner,et al.  Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension , 2007, European journal of nutrition.

[39]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[40]  R. Peto,et al.  Clinical trial methodology , 1978, Nature.